A systematic review and meta-analysis evaluates the efficacy and safety of chimeric antigen receptor T-cell therapy in treating primary central nervous system lymphoma. The findings contribute to understanding potential therapeutic options for this rare malignancy.

Recent research highlights the evolving role of radiotherapy in treating primary central nervous system lymphoma, emphasizing its integration into combined treatment strategies. This study provides insights into optimizing therapeutic approaches for improved patient outcomes.

A study reveals significant racial and socioeconomic disparities affecting survival outcomes in patients with primary central nervous system lymphoma (PCNSL) in the US. The analysis highlights systemic barriers to care and treatment heterogeneity, emphasizing the need for urgent action to address these disparities.

A systematic literature review highlights movement disorders associated with primary central nervous system lymphoma, providing insights into clinical presentations and management strategies. This case study contributes to the understanding of neurological complications linked to this rare malignancy.